Collegium Pharmaceutical (COLL) News Today $30.37 -0.14 (-0.46%) Closing price 07/3/2025 01:48 PM EasternExtended Trading$30.37 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COLL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Janney Montgomery Scott LLC Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)July 4 at 3:10 AM | marketbeat.comCollegium Pharmaceutical's (NASDAQ:COLL) investors will be pleased with their favorable 71% return over the last five yearsJuly 1 at 4:55 AM | uk.finance.yahoo.com5 Insightful Analyst Questions From Collegium Pharmaceutical’s Q1 Earnings CallJuly 1 at 4:55 AM | msn.comCollegium Pharmaceutical: Stock Deserves A 'Buy' Call On Undervaluation Of ADHD DrugJuly 1 at 4:55 AM | seekingalpha.comCollegium Pharmaceutical Announces Share Repurchase Program Worth $25 MillionJuly 1 at 4:55 AM | msn.comANI Pharmaceuticals Shows Rising Relative Price Performance; Still Shy Of Key BenchmarkJune 23, 2025 | msn.comCollegium Pharmaceutical (NASDAQ:COLL) Upgraded by Wall Street Zen to Strong-Buy RatingJune 21, 2025 | marketbeat.comQ1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals StocksJune 20, 2025 | msn.comGAMMA Investing LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 19, 2025 | marketbeat.comExchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 18, 2025 | marketbeat.com1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your RadarJune 17, 2025 | msn.comAssenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 17, 2025 | marketbeat.comJohn G. Freund MD At Collegium Pharmaceutical Decides to Exercises Options Worth $243KJune 12, 2025 | benzinga.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells $202,122.62 in StockJune 12, 2025 | insidertrades.comInsider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Director Sells 6,601 Shares of StockJune 11, 2025 | marketbeat.comCOLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment PrioritiesJune 10, 2025 | msn.comStocks To Watch: Dr. Reddy's Labs ADR Sees Relative Strength Rating Jump To 81June 6, 2025 | msn.comBranded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs PeersJune 6, 2025 | msn.comWellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 6, 2025 | marketbeat.com1 Stock Under $50 with Exciting Potential and 2 to Turn DownJune 4, 2025 | finance.yahoo.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $3.49 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 2, 2025 | marketbeat.comTwo Sigma Investments LP Sells 135,582 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 2, 2025 | marketbeat.comBank of America Corp DE Reduces Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 2, 2025 | marketbeat.comSquarepoint Ops LLC Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)June 1, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 145,300 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 30, 2025 | marketbeat.comMillennium Management LLC Raises Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 30, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ameriprise Financial Inc.May 30, 2025 | marketbeat.comDeutsche Bank AG Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 24, 2025 | marketbeat.comMan Group plc Sells 122,142 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 23, 2025 | marketbeat.comJane Street Group LLC Sells 20,543 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 23, 2025 | marketbeat.comVelan Capital Investment Management LP Purchases New Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 21, 2025 | marketbeat.comGotham Asset Management LLC Sells 24,032 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 21, 2025 | marketbeat.comCollegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft EarningsMay 20, 2025 | finance.yahoo.comJanus Henderson Group PLC Acquires 221,903 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 20, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 20, 2025 | marketbeat.comCollegium to Participate in Upcoming Investor ConferencesMay 19, 2025 | globenewswire.comD. E. Shaw & Co. Inc. Lowers Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 19, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Comerica BankMay 19, 2025 | marketbeat.comNorthern Trust Corp Acquires 20,490 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 19, 2025 | marketbeat.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Quantedge Capital Pte LtdMay 16, 2025 | marketbeat.comCentiva Capital LP Makes New $307,000 Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)May 15, 2025 | marketbeat.comCollegium Pharmaceutical Announces $25 Million Accelerated Share Repurchase Agreement with Jefferies LLCMay 14, 2025 | nasdaq.com9,804 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Brevan Howard Capital Management LPMay 14, 2025 | marketbeat.comCollegium Pharmaceutical enters into accelerated share repurchase agreementMay 12, 2025 | msn.comCollegium Announces $25 Million Accelerated Share Repurchase ProgramMay 12, 2025 | globenewswire.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Acquired by AQR Capital Management LLCMay 12, 2025 | marketbeat.comTruist Financial Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)May 11, 2025 | theglobeandmail.comCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comCollegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 ExpectationsMay 9, 2025 | uk.finance.yahoo.comCollegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansionMay 9, 2025 | msn.com Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address COLL Media Mentions By Week COLL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COLL News Sentiment▼0.810.54▲Average Medical News Sentiment COLL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COLL Articles This Week▼55▲COLL Articles Average Week Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACAD News Today MRUS News Today ACLX News Today SWTX News Today RNA News Today RARE News Today PTGX News Today AAPG News Today SRRK News Today MLTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COLL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COLL Stock Alerts